XXEC Inc. boosted its holdings in Abbott Laboratories (NYSE:ABT – Get Rating) by 2.2% during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 8,909 shares of the healthcare product maker’s stock after acquiring an additional 188 shares during the period. Abbott Laboratories comprises […]
Should You Buy or Sell Abbott Laboratories Stock? Get The Latest ABT Stock Forecast, Price Target, Dividend Info, Headlines, Short Interest at MarketBeat.
XXEC Inc. lowered its stake in shares of Visa Inc. (NYSE:V – Get Rating) by 1.9% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 37,147 shares of the credit-card processor’s stock after selling 721 shares during the quarter. Visa comprises […]